The University of Chicago Header Logo

Connection

Stephanie Mehlis to Receptors, Tumor Necrosis Factor

Back to Details
This is a "connection" page, showing publications Stephanie Mehlis has written about Receptors, Tumor Necrosis Factor.
Stephanie Mehlis
Connection Strength
0.100
Receptors, Tumor Necrosis Factor
  1. Efficacy and safety of briakinumab vs. etanercept and placebo in patients with moderate to severe chronic plaque psoriasis. Br J Dermatol. 2011 Sep; 165(3):652-60.
    View in: PubMed
    Score: 0.100
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.